Synchron Company
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Investors
Founded Date:
2016-04-01
Total Funding:
130000000.0
Investor Type:
Company
Employee Number:
1-10
Investment Stage:
N/A
Funding Status:
Late Stage Venture
Number Of Exists:
Series A
Technology:
['BioTech & HealthTech']
Last Funding Type:
Series C
Investors Number:
23.0
Last Funding Date:
2022-12-15
Industry:
Med Tech
Headquarters:
Brooklyn, New York, United States
Estimated Revenue:
$50M to $100M